ИСТИНА

Fizazi K.

Соавторы: Beer T.M., Chi K.N., Flechon A., Gravis G., Hotte S.J., Jacobs C., Joly F., Malik Z., Saad F., Stewart P., Алексеев Б.Я., Матвеев В.Б., Blumenstein B. показать полностью..., Bokemeyer C., Borch A., Cafferty F.H., Chovanec M., Daugaard G., De Giorgi U., Fabbretti A., Fankhauser C., Feldmann D., Garcia-Del-Muro X., Gietema J.A., Gillessen S., Grimison P., Hansen A., Heidenreich A., Huddart R.A., Kreuter J., Lawrence C.J., Negaard H., Sauvé N., Sweeney C.J., Tandstad T., Terbuch A., Vaughan A., Vecchi A., Wennrich R., Winquist E., Zeng D., de Wit R., Стенберг П., Трякин А.А., Шаман Ю.П.

3 статьи

Количество цитирований статей в журналах по данным Web of Science: 48, Scopus: 75

IstinaResearcherID (IRID): 105380751

Деятельность

• Статьи в журналах

  • 
    • 2021 Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium
    • Gillessen Silke, Sauvé Nicolas, Collette Laurence, Daugaard Gedske, de Wit Ronald, Albany Costantine, Tryakin Alexey, Fizazi Karim, Stahl Olof, Gietema Jourik A., De Giorgi Ugo, Cafferty Fay H., Hansen Aaron R., Tandstad Torgrim, Huddart Robert A., Necchi Andrea, Sweeney Christopher J., Garcia-Del-Muro Xavier, Heng Daniel Y.C., Lorch Anja, Chovanec Michal, Winquist Eric, Grimison Peter, Feldman Darren R., Terbuch Angelika, Hentrich Marcus, Bokemeyer Carsten, Negaard Helene, Fankhauser Christian, Shamash Jonathan, Vaughn David J., Sternberg Cora N., Heidenreich Axel, Beyer Jörg
    • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 39, № 14, с. 1563-1574 DOI
  • 
    • 2017 Custirsen (OGX-011) combined with cabazitaxel and prednisone versus cabazitaxel and prednisone alone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (AFFINITY): a randomised, open-label, phase 3 trial
    • Beer T.M., Hotte S.J., Saad F., Alekseev B., Matveev V., Fléchon A., Gravis G., Joly F., Chi K.N., Malik Z., Blumenstein B., Stewart P.S., Jacobs C.A., Fizazi K.
    • в журнале Lancet Oncology, издательство The Lancet Publishing Group (United Kingdom), том 18, № 11, с. 1532-1542 DOI
  • 
    • 2016 Final overall survival (OS) from the AFFINITY phase 3 trial of custirsen and cabazitaxel/prednisone in men with previously treated metastatic castration-resistant prostate cancer (mCRPC)
    • Fizazi K., Hotte S.J., Saad F., Alekseev B., Matveev V.B., Flechon A., Gravis G., Joly F., Chi K.N., Malik Z., Stewart P., Jacobs C., Beer T.M.
    • в журнале Annals of Oncology, издательство Oxford University Press (United Kingdom), том 27, № 6, с. 1-36 DOI